Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Chief Physician

Biomedical Science · China · 2025-10-31

Processing Time
484 days
Decision Date
2025-10-31
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue critical research using cellular and molecular techniques to elucidate the mechanisms of neurodegenerative diseases. This work aims to facilitate the development of new and improved prognostic and diagnostic tools for medical applications.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor to improve diagnostic tools for neurodegenerative diseases was found to have clear national importance.

2 Well-positioned to Advance the Endeavor Met

The petitioner's 32 publications, 509 citations, and history of major funding demonstrated they are well-positioned.

3 Balance of Interests Met

On balance, it was determined beneficial to the U.S. to waive the labor certification requirement due to the petitioner's significant contributions.

Why This Petition Was Approved

The petition was approved based on 32 peer-reviewed journal articles (5 first-authored) and 2 book chapters that garnered 509 citations. Evidence of major funding from the National Natural Science Foundation of China and active peer review for journals satisfied the Dhanasar prongs.

Request for Evidence (RFE)

Successfully Addressed

The RFE challenged whether the petitioner was well-positioned to advance the endeavor. The response provided meticulous evidence of publications, citations, and external validation through funding.

RFE Targets
Well-positioned to Advance the Endeavor

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience

Similar Cases

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
New York 106 days 2023-01-28
The petitioner proposes to elucidate the genetic mechanisms underlying neurodegenerative diseases using expertise in biochemistry, genetics, and molecular biology. The work focuses on identifying new biological targets for the treatment of Alzheimer’s disease, Parkinson’s disease, and other dementias to provide insights into neuronal degeneration.
View Case

Research Scientist

Biotechnology · South Korea

WeGreened EB-2 (NIW) approved
Massachusetts 5 days 2024-01-30
The petitioner proposes to continue her research elucidating the role of innate immune signaling and cell-type-specific pathway regulation in neurodegenerative diseases. Her work focuses on developing next-generation diagnostics and therapeutics to improve treatment interventions and reduce side effects for patients with neurological disorders.
View Case

Postdoctoral Researcher

Research and Development · Taiwan

WeGreened EB-2 (NIW) approved
Connecticut 90 days 2023-01-19
The petitioner proposes to continue her research on developing novel therapies for neurodegenerative diseases by employing advanced electrophysiological and genetic manipulation techniques. Her work focuses on uncovering neurodegenerative mechanisms to improve therapeutic outcomes for conditions such as Huntington’s, Alzheimer’s, and Parkinson’s disease.
View Case

Data Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
603 days 2025-09-20
The petitioner proposes to develop computational and analytical tools to characterize the mechanisms of chronic and complex diseases. This work involves integrating large-scale biological data to accelerate the discovery of treatment strategies for neurodegenerative disorders and metabolic diseases.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-10-31.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 484 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist